A lecture at the University of MN College of Pharmacy, presented by Mark S. Robbins on April 11, 201 Â The Impact of Hatch Waxman and Antitrust Liability on Incremental Innovation_DOWNLOAD
The Bial 10-2474 Phase 1 Study— A Drug Development Perspective and Recommendations for Future First-
The Bial 10-2474 Phase 1 Study— A Drug Development Perspective and Recommendations for Future First-